Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia
Status:
Completed
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
To the investigator's Knowledge this is the first study that will assess Treatment with
thrombopoietin Mimetic plus immunosuppressiveTherapy in Egyptian Patients with Aplastic
Anaemia.
Aim of the work :
1. To evaluate the efficacy, tolerability and toxicity of the combination of thrombopoietin
mimetic and immunosuppressive therapy in Egyptian patients with AA.
2. To study the influence of this combination on patients' quality of life.
3. To access evolution to paroxysmal nocturnal hemoglobinuria (PNH), myelodysplastic
syndrome , acute leukemia or development of fibrosis